Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2.
Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2.
复制标题
DOI:
10.4049/jimmunol.0901925
复制
发表时间:
2009-12-15
期刊:
影响因子:
--
通讯作者:
Falcone DJ
中科院分区:
文献类型:
--
作者:
Steenport M;Khan KM;Du B;Barnhard SE;Dannenberg AJ;Falcone DJ
MMP-9 (gelatinase B) participates in a variety of diverse physiologic and pathologic processes. We recently characterized a cyclooxygenase-2 (Cox-2)→PGE2→EP4 receptor axis that regulates macrophage MMP-9 expression. In the current studies, we determined whether MMPs, commonly found in inflamed and neoplastic tissues, regulate this prostanoid-EP receptor axis leading to enhanced MMP-9 expression. Results demonstrate that exposure of murine peritoneal macrophages and RAW264.7 macrophages to MMP-1 (collagenase-1) or MMP-3 (stromelysin-1) lead to a marked increase in Cox-2 expression, PGE2 secretion and subsequent induction of MMP-9 expression. Proteinase-induced MMP-9 expression was blocked in macrophages pre-incubated with the selective the Cox-2 inhibitor celecoxib or transfected with Cox-2 siRNA. Likewise, proteinase-induced MMP-9 was blocked in macrophages pre-incubated with the EP4 antagonist ONO-AE3-208 or transfected with EP4 siRNA. Exposure of macrophages to MMP-1 and MMP-3 triggered the rapid release of TNF-α, which was blocked by MMP-inhibitors. Furthermore, both Cox-2 and MMP-9 expression were inhibited in macrophages pre-incubated with anti-TNF-α IgG or transfected with TNF-α siRNA. Thus, proteinase-induced MMP-9 expression by macrophages is dependent on the release of TNF-α, induction of Cox-2 expression and PGE2 engagement of EP4. The ability of MMP-1 and -3 to regulate macrophage secretion of PGE2 and expression of MMP-9 defines a nexus between MMPs and prostanoids that is likely to play a role in the pathogenesis of chronic inflammatory diseases and cancer. These data also suggest that this nexus is targetable utilizing anti-TNF-α therapies and/or selective EP4 antagonists.
登录
查看更多内容
影响因子:
4.8
作者:
Khan, KMF;Laurie, GW;Falcone, DJ
通讯作者:
Falcone, DJ
影响因子:
10.6
作者:
Edwards DR;Handsley MM;Pennington CJ
通讯作者:
Pennington CJ
DOI:
10.1161/01.atv.0000177814.41505.41
发表时间:
2005-09-01
影响因子:
8.7
作者:
Cipollone, F;Fazia, ML;Mezzetti, A
通讯作者:
Mezzetti, A
影响因子:
64.5
作者:
Boire, A;Covic, L;Kuliopulos, A
通讯作者:
Kuliopulos, A
影响因子:
4.8
作者:
Hendrickx, N;Volanti, C;Agostinis, P
通讯作者:
Agostinis, P